Biltmore Family Office’s Celularity CELU Stock Holding History

Biltmore Family Office’s Portfolio CELU Stock Details CELU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$20.9K	Hold	35,000	–	–	﹤0.01%	308
2026 Q1	$46.5K	Hold	35,000	–	–	0.01%	273
2025 Q4	$38.9K	Hold	35,000	–	–	0.01%	277
2025 Q3	$72.5K	Hold	35,000	–	–	0.01%	233
2025 Q2	$68.6K	Hold	35,000	–	–	0.01%	231
2025 Q1	$60.5K	Hold	35,000	–	–	0.01%	220
2024 Q4	$72.8K	Buy	+35,000	New	+$83.5K	0.01%	218
2024 Q1	–	Sell	-35,500	Closed	-$87.8K	–	237
2023 Q4	$87.8K	Sell	35,500 -1,000	-3%	-$2.17K	0.02%	194
2023 Q3	$81.1K	Hold	36,500	–	–	0.02%	191
2023 Q2	$194K	Hold	36,500	–	–	0.04%	178
2023 Q1	$226K	Buy	36,500 +25,150	+222%	+$202K	0.05%	207
2022 Q4	$146K	Buy	11,350 +5,770	+103%	+$106K	0.03%	211
2022 Q3	$129K	Buy	5,580 +3,430	+160%	+$104K	0.03%	170
2022 Q2	$73K	Buy	+2,150	New	+$175K	0.02%	174

Other funds holding CELU

CVSC

C.V. Starr & Co New York $187M AUM 26.03% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

Biltmore Family Office's CELU Position: Q2 2026 in Review

Biltmore Family Office held its Celularity (CELU) position steady in Q2 2026 at 35,000 shares worth $20.9K. The position accounts for ﹤0.01% of the portfolio, ranked #308.

Biltmore Family Office first reported a position in CELU in Q2 2022 and has held it in 14 quarters since. The position peaked at $226K in Q1 2023. 39 funds tracked by Wall St. Rank hold CELU as of Q2 2026.

Biltmore Family Office held 35,000 shares of Celularity worth $20.9K as of Q2 2026.
Biltmore Family Office left its Celularity share count unchanged in Q2 2026.
Celularity made up ﹤0.01% of Biltmore Family Office's portfolio in Q2 2026, its #308 holding.
Biltmore Family Office first reported a position in Celularity in Q2 2022 and has held it in 14 quarters since.
Biltmore Family Office's Celularity position peaked at $226K in Q1 2023.
39 funds tracked by Wall St. Rank held Celularity as of Q2 2026.

Based on Biltmore Family Office's 13F filing for Q2 2026, filed 12 Aug 2026.